Dr. Pineda performed the surgery utilizing donor endothelial tissue that was prepared and pre-loaded into EndoGlide™ (Angiotech Pharmaceuticals, Inc.) cartridges at the Lions Eye Institute for Transplant & Research (LEITR) in Tampa, FL. Massachusetts Eye and Ear cornea surgeon Kathryn Colby, M.D. has also performed surgeries with the pre-loaded tissue.
According to Dr. Pineda, using preloaded donor tissue may minimize potential damage to the endothelial cells and, thus, may lead to better outcomes for the patient.
The procedure – called Endothelial Keratoplasty – allows surgeons to preserve the majority of a recipient’s cornea while replacing the non-functioning or diseased portion of the cornea with a healthy donor tissue.
“Reducing any variables that could interfere with a patient’s ability to successfully regain sight after surgery is significant,” said Dr. Pineda. “The ultimate goal is to improve the quality of life for our patients,” Dr. Pineda said.
A world-leading cornea expert and refractive surgeon at Mass. Eye and Ear, Dr. Pineda has collaborated with LEITR and Angiotech/Sharpoint for the last seven months to help develop the innovative procedure.
“I am pleased that – with Dr. Pineda leading these efforts – Mass. Eye and Ear is at the forefront of implementing an innovative technology that could greatly improve the quality of surgical outcomes for patients facing partial or complete vision loss,” said Joan W. Miller, M.D., FARVO, Chief and Chair of Ophthalmology at Mass. Eye and Ear and Harvard Medical School.
Last year, LEITR reported that eye banks are able to safely prepare and load corneal tissue into the EndoGlide™ cartridges. In a pre-clinical study presented at the 2012 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, corneal buttons pre-loaded by LEITR sustained an average of 9.07% endothelial cell damage, compared to 36.2% endothelial cell damage in control group tissue that was loaded into the insertion system on site. The difference in endothelial damage between the preloaded and control buttons was statistically significant (P = 0.004).
About Massachusetts Eye and Ear
Mass. Eye and Ear clinicians and scientists are driven by a mission to find cures for blindness, deafness and diseases of the head and neck. Mass. Eye and Ear/Schepens is the world’s largest vision and hearing research center, developing new treatments and cures through discovery and innovation. Mass. Eye and Ear is a Harvard Medical School teaching hospital and trains future medical leaders in ophthalmology and otolaryngology, through residency as well as clinical and research fellowships. Internationally acclaimed since its founding in 1824, Mass. Eye and Ear employs full-time, board-certified physicians who offer high-quality and affordable specialty care that ranges from the routine to the very complex. U.S. News & World Report’s “Best Hospitals Survey” has consistently ranked the Mass. Eye and Ear Departments of Otolaryngology and Ophthalmology as top five in the nation. For more information about life-changing care and research, or to learn how you can help, please visit MassEyeAndEar.org.
About the Lions Eye Institute for Transplant & Research (LEITR)
The Lions Eye Institute for Transplant & Research, Inc., (LEITR) is a nonprofit organization dedicated to the recovery, evaluation and distribution of eye tissue for transplantation, research and education. LEITR’s Eye Bank, located in Tampa, FL., is the only combined eye bank and ocular research center in the world. Since its inception, it has brought the “Gift of Sight” to more than 55,000 men, women and children worldwide. For more information, visit www.lionseyeinstitute.org. LEITR is a proud member of Vision Share, a highly organized network of the most innovative and successful eye banks.
Contact: Vannessa Carrington